In this guide, HIV drugs are grouped into nine categories—plus, additional categories for select non-HIV drugs and PrEP
- STR Single-tablet regimen (multiple drug classes)
- LA Long-Acting injectable regimen
- CAI Long-Acting Capsid Assembly Inhibitor
- INSTI integrase strand transfer inhibitor (Integrase inhibitor)
- PI Protease inhibitor
- PKE pharmacokinetic enhancer (booster)
- NRTI Nucleoside reverse transcriptase inhibitor (“nuke”)
- NNRTI Non-nucleoside reverse transcriptase inhibitor (“non-nuke”)
- EI/AI Entry Inhibitor/Attachment Inhibitor
|
BRAND NAME |
CATEGORY |
GENERIC NAME |
|
STR |
efavirenz/emtricitabine/tenofovir DF (EFV/FTC/TDF) |
|
|
STR |
bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) |
|
|
LA |
cabotegravir/rilpivirine long-acting (CAB-LA/RPV LA) injectable |
|
|
NRTI * |
lamivudine/tenofovir DF (3TC/TDF) |
|
|
STR |
rilpivirine/emtricitabine/tenofovir DF (RPV/FTC/TDF) |
|
|
STR |
doravirine/lamivudine/tenofovir DF (DOR/3TC/TDF) |
|
|
NRTI * |
emtricitabine/tenofovir alafenamide (FTC/TAF) |
|
|
STR |
dolutegravir/lamivudine (DTG/3TC) |
|
|
NNRTI |
rilpivirine (RPV) |
|
|
NRTI |
emtricitabine (FTC) |
|
|
NRTI |
lamivudine (3TC) |
|
|
NRTI * |
abacavir/lamivudine (ABC/3TC) |
|
|
PI/PKE |
atazanavir/cobicistat (ATV/COBI) |
|
|
STR |
elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/COBI/FTC/TAF) |
|
|
NNRTI |
etravirine (ETR) |
|
|
INSTI |
raltegravir (RAL) |
|
|
STR |
dolutegravir/rilpivirine (DTG/RPV) |
|
|
PKE |
ritonavir (RTV) |
|
|
STR |
rilpivirine/emtricitabine/tenofovir alafenamide (RPV/FTC/TAF) |
|
|
NNRTI |
doravirine (DOR) |
|
|
PI/PKE |
darunavir/cobicistat (DRV/COBI) |
|
|
PI |
darunavir (DRV) |
|
|
PI |
atazanavir sulfate (ATV) |
|
|
AI |
fostemsavir (FTR) |
|
|
EI |
maraviroc (MVC) |
|
|
STR |
elvitegravir/cobicistat/emtricitabine/tenofovir DF (EVG/COBI/FTC/TDF) |
|
|
CAI |
lenacapavir (LEN) |
|
|
NNRTI |
efavirenz (EFV) |
|
|
STR |
efavirenz/lamivudine/tenofovir DF (EFV//3TC/TDF) |
|
|
STR |
darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DRV/COBI/FTC/TAF) |
|
|
NRTI * |
lamivudine/tenofovir DF (3TC/TDF) |
|
|
INSTI |
dolutegravir (DTG) |
|
|
STR |
dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) |
|
|
EI |
ibalizumab-uiyk (IBA) |
|
|
NRTI * |
emtricitabine/tenofovir DF (FTC/TDF) |
|
|
PKE |
cobicistat (COBI) |
|
|
NRTI |
tenofovir disoproxil fumarate (tenofovir DF, or TDF) |
|
|
NRTI |
abacavir sulfate (ABC) |
|
|
* Fixed-dose combination of two drugs from the same drug class. |
||
|
HIV prevention |
||
|
PrEP |
cabotegravir extended-release injectable suspension (CAB-LA) |
|
|
PrEP |
emtricitabine/tenofovir alafenamide (FTC/TAF) |
|
|
PrEP |
emtricitabine/tenofovir DF (FTC/TDF) |
|
|
Non-HIV drugs |
||
|
tesamorelin for injection |
for HIV-related hard belly fat |
|
|
crofelemer |
for HIV/AIDS-associated diarrhea |
|
|
somatropin for injection |
for HIV-related wasting |
|